Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

BACKGROUND AND AIMS: Treatment of hepatitis C virus (HCV) infection has significantly changed during the last few years. The combination of ledipasvir and sofosbuvir has been shown to treat high proportions of patients with HCV genotype 1 with remarkable tolerability. The aim of the work was to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ossama A, Kaisar, Hany H, Badawi, Rehab, Hawash, Nehad, Samir, Hossam, Shabana, Sherif ST, Fouad, Mohamed Hassan A, Rizk, Fatma H, Khodeir, Samy A, Abd-Elsalam, Sherief
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840188/
https://www.ncbi.nlm.nih.gov/pubmed/29535545
http://dx.doi.org/10.2147/IDR.S153060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840188/
https://www.ncbi.nlm.nih.gov/pubmed/29535545
http://dx.doi.org/10.2147/IDR.S153060

Ejemplares similares